<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2021 16_9-10_289</article-id>
<article-id pub-id-type="doi">10.15836/ccar2021.289</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Aortic valve / treatment challenges</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5664-1873</contrib-id><name><surname>&#x0106;ubela</surname><given-names>Vlado-Vlaho</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2620-3194</contrib-id><name><surname>Dragi&#x010D;evi&#x0107;</surname><given-names>Maro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1482-6503</contrib-id><name><surname>Bulum</surname><given-names>Jo&#x0161;ko</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7025-0932</contrib-id><name><surname>Filipec Kani&#x017E;aj</surname><given-names>Tajana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1650-4735</contrib-id><name><surname>Jerki&#x0107;</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital &#x201C;Merkur&#x201D;</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff3"><label>3</label><institution>University of Zagreb</institution>, <institution content-type="dept">School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Helena Jerki&#x0107;, Klini&#x010D;ka bolnica Merkur, Zaj&#x010D;eva 19, HR-10000 Zagreb, Croatia. / Phone: +385-99-4888-576 / E-mail: <email xlink:href="helenajerkic@yahoo.com">helenajerkic@yahoo.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>09</month><year>2021</year></pub-date>
<volume>16</volume>
<issue>9-10</issue>
<fpage>289</fpage>
<lpage>289</lpage>
<history>
<date date-type="received"><day>15</day><month>07</month><year>2021</year></date>
<date date-type="accepted"><day>05</day><month>08</month><year>2021</year></date>
</history>
<permissions>
<copyright-year>2021</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>balloon aortic valvuloplasty</kwd><kwd>aortic stenosis</kwd><kwd>end-stage liver disease</kwd><kwd>orthotopic liver transplantation</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Severe aortic stenosis (AS) in patients with end-stage liver disease (ESLD) increases the morbidity and mortality of orthotopic liver transplantation (OLT). OLT is a surgical intervention with serious hemodynamic changes which can contribute to heart failure and cardiac death. Due to increased perioperative mortality, severe AS and ESLD are considered contraindications for OLT or aortic valve replacement (AVR) (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). Aortic balloon valvuloplasty (BAV) may be a reasonable therapeutic option to improve the hemodynamic status and enable OLT (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>).</p>
<p><bold>Case report:</bold> The patient was a 43-year-old female who had an OLT in 2019 due to fulminant hepatitis B. AS was detected in 2018 and it progressed to severe in 2021. In 2021, another decompensation of cirrhosis of the liver graft occurred. The patient had Child-Pugh B graft cirrhosis which is according to the available data, contraindication for cardiac surgery (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). A multidisciplinary meeting was held and it was decided to do a BAV as a less invasive procedure before OLT. BAV was made with a satisfactory reduction of the transvalvular pressure gradient by 30% and with this procedure, the patient is hemodynamically in a more favorable position for OLT.</p>
<p><bold>Discussion</bold>: BAV was presented as a minimally invasive procedure with fewer complications to surgical replacement for AS in patient with ESLD. In practice, the procedure was proved to have a high percentage of complications and only a modest hemodynamic upgrade compared with AVR. Therefore, valvuloplasty should not be the first choice for AS. However, there are some indications for BAV such as a palliative treatment and in patients with AS and ESLD as a bridging procedure to OLT (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). This procedure enabled our patient to undergo surgery in a hemodynamically more favorable situation. It is also necessary to say that a multidisciplinary approach involving gastroenterologists, cardiologists, cardiac and abdominal surgeons, and anesthesiologists is the key in the treatment of such patients. In conclusion, in patients who are unsuitable for OLT because of AS, BAV, and then OLT may be a good approach that permits AVR posttransplantation. However further research is needed to demonstrate the advantages and disadvantages of this approach.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalarickal</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Rathor</surname><given-names>R</given-names></name><name><surname>Ishag</surname><given-names>S</given-names></name><name><surname>Kerr</surname><given-names>T</given-names></name><name><surname>Kangrga</surname><given-names>I</given-names></name></person-group>. <article-title>Balloon aortic valvuloplasty as a bridge to liver transplantation in patients with severe aortic stenosis: a case series.</article-title> <source>Transplant Proc</source>. <year>2014</year>;<volume>46</volume>(<issue>10</issue>):<fpage>3492</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2014.08.035</pub-id><pub-id pub-id-type="pmid">25498078</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coverstone</surname><given-names>E</given-names></name><name><surname>Korenblat</surname><given-names>K</given-names></name><name><surname>Crippin</surname><given-names>JS</given-names></name><name><surname>Chapman</surname><given-names>WC</given-names></name><name><surname>Kates</surname><given-names>AM</given-names></name><name><surname>Zajarias</surname><given-names>A</given-names></name></person-group>. <article-title>Aortic balloon valvuloplasty prior to orthotopic liver transplantation: a novel approach to aortic stenosis and end-stage liver disease.</article-title> <source>Case Rep Cardiol</source>. <year>2014</year>;<volume>2014</volume>:<elocation-id>325136</elocation-id>. <pub-id pub-id-type="doi">10.1155/2014/325136</pub-id><pub-id pub-id-type="pmid">25431682</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>KA</given-names></name><name><surname>Hjortnaes</surname><given-names>J</given-names></name><name><surname>Kranenburg</surname><given-names>G</given-names></name><name><surname>de Heer</surname><given-names>F</given-names></name><name><surname>Kluin</surname><given-names>J</given-names></name></person-group>. <article-title>Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score.</article-title> <source>Interact Cardiovasc Thorac Surg</source>. <year>2015</year>;<volume>20</volume>(<issue>4</issue>):<fpage>520</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivu438</pub-id><pub-id pub-id-type="pmid">25612743</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
